Lobular carcinoma in situ: What clinicians need to know

Hospital Practice

Volumn 28, Issue 6, 1993, Pages

  Grooff, P N ^a   Pamies, R J ^a   Hunyadi, S ^a  

^a Mt Sinai Medical Center Cleveland   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

BREAST CARCINOMA; CANCER HORMONE THERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CARCINOMA IN SITU; CLINICAL FEATURE; HISTOPATHOLOGY; HUMAN; MASTECTOMY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT;

EID: 0027263875     PISSN: 87502836     EISSN: None     Source Type: Journal    
DOI: 10.1080/21548331.1993.11442810     Document Type: Review

References (14)

1. Surg Clin North Am Gump FE 873 70 1990 10.1016/S0039-6109(16)45186-8
2. Arch Surg Walt A J 904 127 1992 10.1001/archsurg.1992.01420080038006
3. Can J Surg Donegan WL 361 35 1992
4. In Diagnosis and Management of Breast Cancer Swain SM 296 1988
5. Eur J Surg Oncol Salvadori B 35 27 1991
6. Oncology Swain SM 35 3 3 1989
7. Breast Cancer Res Treat Posner MC 155 21 3 1991 10.1007/BF01974998
8. Eur J Surg Oncol Ringberg A 20 17 1991
9. Acta Oncol Fentiman IS 923 28 1989 10.3109/02841868909092333
10. Eur J Surg Oncol Graham MD 258 17 1991
11. Cancer Wheeler JE 554 34 1974 10.1002/1097-0142(197409)34:3<554::AID-CNCR2820340313>3.0.CO;2-7
12. Cancer Andersen JA 2597 39 1977 10.1002/1097-0142(197706)39:6<2597::AID-CNCR2820390644>3.0.CO;2-E
13. Am J Surg Pathol Rosen PP 225 2 1978 10.1097/00000478-197809000-00001
14. Cancer Haagensen CD 737 42 1978 10.1002/1097-0142(197808)42:2<737::AID-CNCR2820420247>3.0.CO;2-T